A patent review of the therapeutic potential of isoflavones (2012-2016)

References

• Reinsch H. Chemische untersuchung der Wurzel von Onionis spinosa. Repert Pharm. 1842;26:12–31.
   Google Scholar
• Reinsch H. Chemische untersuchung der Wurzel von Onionis spinose. Repert Pharm. 1842;28:18–25.
   Google Scholar
• Hlasiwetz H. Ueber die Wurzel der Onionis spinose. J Prakt Chem. 1855;65:419–450.
   Google Scholar
• Hlasiwetz H. Ueber die Wurzel der Onionis spinose. Sitzungsber Kais Akad Wiss Wien Math-Naturwiss. Kl. 1855;15:142–168.
   Google Scholar
• Baker W, Robinson R, Simpson NM. 75. Synthetical experiments in the isoflavone group. Part VII. Synthesis of daidzein. J Chem Soc. 1933;274–275.
   Google Scholar
• Veitch NC. Isoflavonoids of the leguminosae. Nat Prod Rep. 2007;24:417–464.
   PubMed Web of Science ®Google Scholar
• Veitch NC. Isoflavonoids of the leguminosae. Nat Prod Rep. 2013;30:988–1027.
   PubMed Web of Science ®Google Scholar
• Veitch NC. Isoflavonoids of the leguminosae. Nat Prod Rep. 2009;26:776–802.
   PubMed Web of Science ®Google Scholar
• Lapcık O. Isoflavonoids in non-leguminous taxa: a rarity or a rule? Phytochemistry. 2007;68:2909–2916.
   PubMed Web of Science ®Google Scholar
• Wang H, Cui Y, Zhao C. Flavonoids of the Genus Iris (Iridaceae). Mini-Rev Med Chem. 2010;10:643–661.
   PubMed Web of Science ®Google Scholar
• Harborne JB. Chemosystematics of the leguminosae flavonoid and isoflavonoid patterns in the tribe genisteae. Phytochemistry. 1969;8:1449–1456.
   Web of Science ®Google Scholar
• Oleszek W, Stochmal A, Janda B. Concentration of isoflavones and other phenolics in the aerial parts of Trifolium species. J Agric Food Chem. 2007;55:8095–8100.
   PubMed Web of Science ®Google Scholar
• Spagnuolo C, Russo GL, Orhan IE, et al. Genistein and cancer: current status, challenges, and future directions. Am Soc Nutrition Adv Nutr. 2015;6:408–419.
   PubMed Web of Science ®Google Scholar
• Chodon D, Ramamurty N, Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line. Toxicol In Vitro. 2007;21:887–891.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhu CF, Iwamoto H, et al. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J Gastroenterol. 2005;11:6512–6517.
   PubMed Web of Science ®Google Scholar
• Yeh TC, Chiang PC, Li TK, et al. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol. 2007;73:782–792.
   PubMed Web of Science ®Google Scholar
• Mansoor TA, Ramalho RM, Luo X, et al. Isoflavones as apoptosis inducers in human hepatoma HuH-7 cells. Phytother Res. 2011;25:1819–1824.
   PubMed Web of Science ®Google Scholar
• Zhou HB, Chen JJ, Wang WX, et al. Apoptosis of human primary gastric carcinoma cells induced by genistein. World J Gastroenterol. 2004;10:1822–1825.
   PubMed Web of Science ®Google Scholar
• Tatsuta M, Iishi H, Baba M, et al. Attenuation by genistein of sodium-chloride- enhanced gastric carcinogenesis induced by N-methyl-N 9 -nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer. 1999;80:396–399.
   PubMed Web of Science ®Google Scholar
• Yanagihara K, Takigahira M, Mihara K, et al. Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers. Nutr Cancer. 2013;65:578–589.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhu CF, Dai YL, et al. Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma. World J Gastroenterol. 2009;15:4952–4957.
   PubMed Web of Science ®Google Scholar
• Zhu H, Cheng H, Ren Y, et al. Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo. Mol Biol Rep. 2012;39:4971–4979.
   PubMed Web of Science ®Google Scholar
• Mahmood J, Jelveh S, Calveley V, et al. Mitigation of radiation-induced lung injury by genistein and EUK-207. Int J Radiat Biol. 2011;87:889–901.
   PubMed Web of Science ®Google Scholar
• Gadgeel SM, Ali S, Philip PA, et al. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer. 2009;115:2165–2176.
   PubMed Web of Science ®Google Scholar
• Wu TC, Yang YC, Huang PR, et al. Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1. Toxicol Appl Pharmacol. 2012;262:247–254.
   PubMed Web of Science ®Google Scholar
• Kim YS, Choi KC, Hwang KA. Genistein suppressed epithelial–mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF- β signaling pathway. Phytomedicine. 2015;22:993–999.
   PubMed Web of Science ®Google Scholar
• Gatouillat G, Magid AA, Bertin E, et al. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells. Phytomedicine. 2015;22:1186–1194.
   PubMed Web of Science ®Google Scholar
• Huang HL, Hsieh MJ, Chien MH, et al. Glabridin mediate caspases activation and induces apoptosis through JNK1/2 and p38 MAPK pathway in human promyelocytic leukemia cells. PLoS One. 2014;9:e98943.
   PubMed Web of Science ®Google Scholar
• Hsieh MJ, Chen MK, Chen CJ, et al. Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells. Phytomedicine. 2016;23:359–366.
   PubMed Web of Science ®Google Scholar
• Cunha-Rodrigues M, Portugal S, Prudencio M, et al. Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy. PLoS One. 2008;3:e2732.
   PubMed Web of Science ®Google Scholar
• Ha YR, Kang YJ, Lee SJ, et al. In vivo study on splenomegaly inhibition by genistein in Plasmodium berghei-infected mice. Parasitol Int. 2015;64:369–376.
   PubMed Web of Science ®Google Scholar
• Cheema HS, Prakash O, Pal A, et al. Glabridin induces oxidative stress mediated apoptosis like cell death of malaria parasite Plasmodium falciparum. Parasitol Int. 2014;63:349–358.
   PubMed Web of Science ®Google Scholar
• Adams SM, Aksenova MV, Aksenov MY, et al. Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat1–86 exposure. PLoS One. 2012;7:e37540.
   PubMed Web of Science ®Google Scholar
• Guo J, Xu X, Rasheed TK, et al. Genistein interferes with SDF-1- and HIV-mediated actin dynamics and inhibits HIV infection of resting CD4 T cells. Retrovirology. 2013;10:62–76.
   PubMed Web of Science ®Google Scholar
• Sathyapalan T, Rigby AS, Bhasin S, et al. Effect of soy in men with type 2 diabetes mellitus and subclinical hypogonadism - A randomized controlled study. J Clin Endocrinol Metab. 2017;102:425–433.
   PubMed Web of Science ®Google Scholar
• Chi XX, Zhang T, Zhang DJ, et al. Effects of isoflavones on lipid and apolipoprotein levels in patients with type 2 diabetes in Heilongjiang Province in China. J Clin Biochem Nutr. 2016;59:134–138.
   PubMed Web of Science ®Google Scholar
• Panneerselvam S, Packirisamy RM, Bobby Z, et al. Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity). J Nutr Biochem. 2016;38:57–69.
   PubMed Web of Science ®Google Scholar
• Odle B, Dennison N, Al-Nakkash L, et al. Genistein treatment improves fracture resistance in obese diabetic mice. BMC Endocr Disord. 2017;9;17:1.
   Web of Science ®Google Scholar
• Ding M, Pan A, Manson JE, et al. Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohorts. Eur J Clin Nutr. 2016;70:1381–1387.
   PubMed Web of Science ®Google Scholar
• Hajrezaie M, Salehen NA, Karimian H, et al. Biochanin A gastroprotective effects in ethanol-induced gastric mucosal ulceration in rats. PLoS One. 2015;10:e0121529.
   PubMed Web of Science ®Google Scholar
• Hügel HM, Jackson N, May B, et al. Polyphenol protection and treatment of hypertension. Phytomedicine. 2016;15(23):220–231.
   Web of Science ®Google Scholar
• Liao X, Jia Y, Gong S, et al. Isoflavone compound, preparation method and application thereof in preparing antitumor active medicine. CN104592189A. 2015.
   Google Scholar
• Chen H, Jin L, Liu J, et al. Application of isoflavone compound in antitumor medicine or food. CN102309479A. 2012.
   Google Scholar
• Zhang X, Chen H, Chen Z, et al. Application of 4ʹ-methoxy-7-hydroxy isoflavone for preparing antineoplastic drug and the preparation method thereof. CN102584767A. 2012.
   Google Scholar
• Liu Z, Pan D, Guan Y, et al. Flavonoid compound targeting cancer cell and preparation method thereof. CN106008481A. 2016.
   Google Scholar
• Yan X, Liu H. Application of isoflavone carboxylate salt derivative in inhibiting human cervical carcinoma Hela cell propagation. CN105963290A. 2016.
   Google Scholar
• Roman DL, Mackie DI. Methods of using therapeutic compounds that modulate G Protein Signaling (RGS) proteins and of treating diseases such as cancer. US20160264616A1. 2016.
   Google Scholar
• Yan X, Liu H, Liu H. Application of isoflavone derivative in inhibiting propagation of lung adenocarcinoma A549 cell. CN105497009A. 2016.
   Google Scholar
• Wong KW, Law YK, Efferth T, et al. Prenylated isoflavones for treatment of subjects with multidrug-resistant cancer. AU2015101721A4. 2015.
   Google Scholar
• Park GW, Lee SC, Song NJ, et al. Flavonoids for preventing and treating lymphedema. US20160081974A1. 2016.
   Google Scholar
• Kaneda N, Tanaka HA. Glyoxalase I inhibitor, antitumor agent, and screening method for them. JP2015081251A. 2015.
   Google Scholar
• Bai W, Sun C, Sun J, et al. Application of isoflavone compounds to preparing medicines or health care products with anti-tumor effect. CN104490863A. 2015.
   Google Scholar
• Li H, Liang Y, Lu Q. Isoflavone (flemiphilippinin A) with high anti-tumor activity extracted from Flemingia philippinensis root for treating cancers. CN103275099A. 2013.
   Google Scholar
• Hu X, Zhou D, Tuo W, et al. 7,4ʹ-Disubstituted isoflavone derivatives, preparation method and application. CN103145676A. 2013.
   Google Scholar
• Yuan N, Xia Y, Min Y. Application of isoflavones constituents for preparation of medicines for preventing and/or treating cancer. CN102949388A. 2013.
   Google Scholar
• Wu J, Shi D, Wang Y, et al. Application of 4ʹ,5-dihydroxy-7-[4-(N,N-diethylamino)butoxy]isoflavone for preparing antitumor drug. CN102309478A. 2012.
   Google Scholar
• Dong H, Zhang M, Wang Y, et al. Preparation of isoflavone compounds as antiviral and antitumor agents. CN102617536A. 2012.
   Google Scholar
• Merson MH. The HIV–AIDS pandemic at 25-The global response. Engl J Med. 2006;354:2414–2417.
   PubMed Web of Science ®Google Scholar
• Liu L, Chen Z, Chen J, et al. Use of isoflavones for the treatment of retroviral infection. WO2015090201A1. 2015.
   Google Scholar
• Huang C, Li Z, Fan M, et al. Application of an isoflavone compound in preparing drugs for preventing and treating viral diseases. CN102302484A. 2012.
   Google Scholar
• Xiao Z, Wang X, Li J, et al. Isoflavone-N-methyl hydroxamic acids urease inhibitor, its synthesis and application in preparing anti-gastritis and anti-gastric ulcer drugs. CN102993153A. 2013.
   Google Scholar
• Xiao Z, Wang X, Ouyang H, et al. Isoflavone hydroxamic acids urease inhibitor, its synthesis and application in preparing anti-gastritis and anti-gastric ulcer drugs. CN102993152A. 2013.
   Google Scholar
• Vishnuvathan VJ, Lakshmi KS, Srividya AR. Medicinal uses of formononetin- a review. J Ethnobiology Traditional Med. 2016;126:1197–1209.
   Google Scholar
• Zhu M. Application of 7-hydroxy-4ʹ-methoxy-isoflavone in preparation of antifungal drugs. CN103565794A. 2014.
   Google Scholar
• Zhang BA. Application of isoflavones in preparation of anti-Cryptosporidium parvum medicine. CN104688726A. 2015.
   Google Scholar
• Li T, Chen Z, Yang G, et al. Isoflavonoid compound from tobacco rhizome and preparation and application thereof. CN 102351827A. 2012.
   Google Scholar
• Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2014;42:698–702.
   Google Scholar
• Xiang H, Xu P, Qian Z, et al. Homoisoflavone aromatic acid-aryl esters and their preparation, pharmaceutical compositions and use in the treatment of hyperlipidemia, obesity or type II diabetes. CN105732561A. 2016.
   Google Scholar
• Xiang H, Xu P, Wang W, et al. Preparation of isoflavone amide derivatives as cholesterol ester transfer protein inhibitors. CN105541777A. 2016.
   Google Scholar
• Xiang H, Wang W, Xiao H, et al. Preparation of isoflavone amide derivatives for treatment of hyperlipemia, obesity or type 2 diabetes. CN 104672192A. 2015.
   Google Scholar
• Xiang H, He Y, Zhao W, et al. Preparation of isoflavone or flavonoid ether derivatives for preventing or treating hyperlipidemia, adiposity and type II diabetes. CN102964322A. 2013.
   Google Scholar
• Chou G, Sun Q, Zhang Y. Isoflavone derivative and its preparing method and application. CN104341404A. 2015.
   Google Scholar
• Iadonato SP, Bedard KM, Fowler KW. Anti-viral compounds, pharmaceutical compositions, and methods of use. WO2015009812A2. 2015.
   Google Scholar
• Zhang S. Ringlike flavone or isoflavone compound useful in treatment of hepatitis C and their preparation. CN104610272A. 2015.
   Google Scholar
• Yu Z, Zhao Y, Bai Y. Extraction of isoflavone glycoside compound for preventing and treating diseases caused by excessive free radicals. CN105949257A. 2016.
   Google Scholar
• Tan R, Shi D, Wu J, et al. 4ʹ,5-dihydroxy-7-[4-(N,N-diethylamino)butoxy]isoflavone, its preparation and medical application. WO 2012075849A1. 2012.
   Google Scholar
• Deng Y, Yuan W, Sang Z, et al. Preparation of isoflavone carbamates for treating and/or preventing neurodegenerative diseases. CN102827131A. 2012.
   Google Scholar
• Si C, Wang G, Huo D, et al. Preparation method and anti-inflammatory application of isoflavone glycoside in green peel of Juglans sigillata. CN105646621A. 2016.
   Google Scholar
• Yagi M, Yonei Y, Mitsuhashi K, et al. Anti-glycation agents containing isoflavone aglycons or isoflavanone aglycons. JP2015209423A. 2015.
   Google Scholar
• Yan X, Liu H Isoflavone derivative and its application in resistance to red blood cell hemolysis. CN 105616399A. 2016.
   Google Scholar
• Grynkiewicz G, Wegrzyn G, Szechner B, et al. Isoflavones for treating mucopolysaccharidoses. US20140107051A1. 2014.
   Google Scholar
• Qiu G, Qiu Q. Soybean isoflavone derivative as β-adrenergic blocking agents and its preparation. CN103121985A. 2013.
   Google Scholar
• Misawa N, Hattan J, Shindo K. Novel isoflavone glycosides, androgen receptor-binding composition, and antiandrogen composition containing the same. JP2014118367A. 2014.
   Google Scholar
• Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999;129:758S–767S.
   PubMed Web of Science ®Google Scholar
• Kwon SH, Kang MJ, Huh JS, et al. Comparison of oral bioavailability of genistein and genistin in rats. Int J Pharm. 2007;337:148–154.
   PubMed Web of Science ®Google Scholar
• Russo M, Russo GL, Daglia M, et al. Understanding genistein in cancer: the “good” and the “bad” effects: A review. Food Chem. 2016;196:589–600.
   PubMed Web of Science ®Google Scholar
• Xiong P, Wang R, Zhang X, et al. Design, synthesis, and evaluation of genistein analogues as anti-cancer agents. Anticancer Agents Med Chem. 2015;15:1197–1203.
   PubMed Web of Science ®Google Scholar
• Ullmann U, Bendik I, Flühmann B. Bonistein (synthetic genistein) a food component in development for a bone health nutraceutical. J Physiol Pharmacol. 2005;56:79–95.
   PubMedGoogle Scholar
• Yuan L, Wagatsuma C, Sun B, et al. The role of beta-glucuronidase in induction of apoptosis by genistein combined polysaccharide in xenogeneic mice bearing human mammary cancer cells. Ann N Y Acad Sci. USA. 2003;1010:347–349.
   PubMed Web of Science ®Google Scholar
• Squadrito F, Bitto A, Marini H, et al. Genistein aglycone effectively manages postmenopausal bone loss. J Clin Densit. 2009;12:396–396.
   Google Scholar
• Rusin A, Krawczyk Z, Grynkiewicz G, et al. Synthetic derivatives of genistein, their properties and possible applications. Acta Biochim Pol. 2010;57:23–34.
   PubMed Web of Science ®Google Scholar
• Yang Z, Kulkarni K, Zhu W, et al. Bioavailability and pharmacokinetics of genistein:mechanistic studies on its ADME. Anticancer Agents Med Chem. 2012;12:1264–1280.
   PubMed Web of Science ®Google Scholar
• Ren W, Qiao Z, Wang H, et al. Flavonoids: promising anticancer agents. Med Res Rev. 2003;23:519–534.
   PubMed Web of Science ®Google Scholar